LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 8.939
EU - Europa 5.567
AS - Asia 2.021
AF - Africa 217
SA - Sud America 29
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 5
Totale 16.803
Nazione #
US - Stati Uniti d'America 8.920
UA - Ucraina 1.388
SE - Svezia 832
IT - Italia 736
IE - Irlanda 705
TR - Turchia 647
SG - Singapore 636
DE - Germania 633
DK - Danimarca 539
CN - Cina 385
FI - Finlandia 315
KR - Corea 290
GB - Regno Unito 182
FR - Francia 167
CI - Costa d'Avorio 113
MA - Marocco 101
IN - India 41
BE - Belgio 27
BR - Brasile 27
EU - Europa 25
CA - Canada 16
RU - Federazione Russa 14
CZ - Repubblica Ceca 7
HK - Hong Kong 6
AU - Australia 4
ES - Italia 4
GR - Grecia 4
JP - Giappone 4
BZ - Belize 3
CH - Svizzera 3
NL - Olanda 3
PL - Polonia 3
BD - Bangladesh 2
HR - Croazia 2
PK - Pakistan 2
TH - Thailandia 2
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
IR - Iran 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
TN - Tunisia 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 16.803
Città #
Jacksonville 1.423
Chandler 1.049
Fairfield 779
Boardman 704
Dublin 703
Wilmington 473
Ashburn 468
Woodbridge 350
San Mateo 291
Houston 288
Lawrence 286
Princeton 286
Seattle 279
New York 273
Singapore 272
Des Moines 233
Cambridge 212
Ann Arbor 189
Centro 166
San Diego 116
Abidjan 113
Redmond 93
Porto 79
Beijing 73
Turin 53
Shanghai 42
Milan 37
Los Angeles 35
Guangzhou 32
Helsinki 30
Pune 29
Norwalk 27
Pianella 27
Brussels 25
London 25
Marche 23
Dallas 19
Izmir 18
Auburn Hills 16
Civitanova Marche 15
Wuhan 15
Washington 12
Jinhua 10
Prescot 10
Rome 10
Venice 10
Wuxi 10
Falls Church 9
New Bedfont 8
Ancona 7
Olomouc 7
Catania 6
Fayetteville 6
Hyderabad 6
Jesi 6
Jiaxing 6
Kilburn 6
Ottawa 6
Shenzhen 6
Chiswick 5
Frankfurt am Main 5
Hangzhou 5
Hong Kong 5
Leeds 5
Quanzhou 5
Bari 4
Bristol 4
Corato 4
Montréal 4
Naples 4
Seoul 4
Toronto 4
Yiwu 4
Acton 3
Bologna 3
Florence 3
Hanover 3
Istanbul 3
Nürnberg 3
Park Ridge 3
Phoenix 3
Pistoia 3
San Benedetto Del Tronto 3
Santa Clara 3
Stockholm 3
Sydney 3
Vercelli 3
Wandsworth 3
Andria 2
Athens 2
Bangkok 2
Bergamo 2
Bern 2
Cagli 2
Caserta 2
Chengdu 2
Chongqing 2
Dalian 2
Delhi 2
Dongyang 2
Totale 9.938
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 192
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 138
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 126
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 121
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 114
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 112
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 109
Glial-like differentiation potential of human mature adipocytes 109
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 103
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 103
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 102
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 102
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 100
Meningioma-like cerebral relapse of Hodgkin's disease. 100
Primary B-cell lymphoblastic lymphoma of the testis 100
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 98
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 96
Plasticity of human dedifferentiated adipocytes toward endothelial cells 95
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 95
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 94
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 93
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 92
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 91
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 90
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 90
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 90
Biosafety evidence for human dedifferentiated adipocytes 90
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 89
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 89
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 89
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 88
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 88
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 87
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 86
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 86
Molecular and functional characterization of human bone marrow adipocytes 85
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 84
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 83
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 83
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 82
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 82
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 82
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 82
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 81
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 80
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 80
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 79
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 78
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 78
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 78
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 78
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 78
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 78
The value of PCR in the diagnosis and monitoring of early stage of mycosis fungoids treated with Interferon plus PUVA 78
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 77
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 77
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 77
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 77
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 77
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 77
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 77
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 77
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 77
High remission rate in T-Cell prolymphocytic leukemia with Campath-1H 76
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 75
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 75
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 75
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 75
Risk assessment of patients with Hematologic malignancies who develop fever accompanied by pulmonary infiltrates. A historic cohort study. 74
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 74
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 73
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 73
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 73
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 73
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 72
Bone marrow adipocytes support haematopoietic stem cell survival 72
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 72
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 71
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 71
[Hodgkin's lymphoma and secondary leukemias]. 71
Risk of non-Hodgkin lymphoma in celiac disease 70
Clonal TCR gamma e TCR delta rearrangement in peripheral blood in MF/SS patients 70
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 70
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 70
Treatment of adult acute lymphoblastic leukemia (ALL): Long-Term Follow-up of the GIMEMA ALL 0288 randomize study 69
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 69
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 69
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 69
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 68
Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center 68
Signet ring cells are not uncommon in cutaneous B-cell lymphoma and seem not to be associated with a specific clinical behaviour 68
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 68
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 68
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 68
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. 68
Response to fludarabina in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy 67
Risk of Thromboembolic Events in ET and Early / Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis 66
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 66
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome 66
Identification of different adypocytes populations within human marrow microenvironment 66
Totale 8.377
Categoria #
all - tutte 93.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.044 0 0 0 0 0 4 292 9 298 12 84 345
2020/20213.524 145 386 545 38 471 193 358 162 426 266 388 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20251.306 429 424 172 48 169 64 0 0 0 0 0 0
Totale 17.164